Clinical Trials · NCT05705388
POSE2.0 With GLP-1 Agonist for Obesity Management
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Emirates Health Services (EHS)
- Enrollment
- 50
- Start date
- Jan 2023
- Locations
- 1 site, United Arab Emirates
- Primary endpoint
- Mean percent total body weight loss at 6 months in each arm of the study